Overview Drug-drug Interaction of BI 201335 and Microgynon Status: Completed Trial end date: 2012-08-01 Target enrollment: Participant gender: Summary This study will investigate possible effect of multiple oral doses of BI 201335 on the steady state pharmacokinetics of ethinylestradiol and levonogestrel Phase: Phase 1 Details Lead Sponsor: Boehringer IngelheimTreatments: Ethinyl EstradiolEthinyl Estradiol-Norgestrel CombinationEthinyl estradiol, levonorgestrel drug combinationLevonorgestrel